Arvin Yang

Insider Reports History

Location
Cambridge, MA
Signature
/s/Alejandra Carvajal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arvin Yang:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mersana Therapeutics, Inc. SVP, Chief Medical Officer Common Stock 30,821 $83,525 $2.71 17 Jan 2023 Direct
Mersana Therapeutics, Inc. SVP, Chief Medical Officer Restricted stock unit 21,249 $57,585 $2.71 14 Jan 2023 Direct
Mersana Therapeutics, Inc. SVP, Chief Medical Officer Stock option (right to buy) 217,500 13 Jan 2023 Direct

Insider Reports Filed by Arvin Yang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRSN Mersana Therapeutics, Inc. 13 Jan 2023 5 -$12,680 4 SVP, Chief Medical Officer 18 Jan 2023, 19:29
MRSN Mersana Therapeutics, Inc. 30 Nov 2022 3 -$36,423 4 Chief Medical Officer 02 Dec 2022, 15:01
MRSN Mersana Therapeutics, Inc. 14 Jan 2022 2 $0 4 Chief Medical Officer 19 Jan 2022, 16:59
MRSN Mersana Therapeutics, Inc. 30 Nov 2021 3 -$37,639 4 Chief Medical Officer 02 Dec 2021, 16:00